Giffin Brett A.
- SEC CIK
- 0001892921
No open-market purchases or sales filed in the past year.
Current role at each company
- TTOO T2 Biosystems, Inc.Chief Commercial Officeras of Jan 2, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Giffin Brett A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 28, 2023 (view filing) | Feb 20 | 281 days | Giffin Brett A.Chief Commercial Officer | SSale | −537 | $0.65 | −$349.05 | −15.0%3.05K after | Amended |
| Nov 22, 2022 (view filing) | Nov 10 | 12 daysLate | Giffin Brett A.Chief Commercial Officer | SSale | −1.29K | $1.79 | −$2.31K | −36.4%2.25K after | |
| Apr 11, 2022 (view filing)9:38 AM ET | Apr 8 | 3 days | Giffin Brett A.Chief Commercial Officer | PPurchase | +10.6K | $0.489 | +$5.18K | New position10.6K after |